Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2022 2
2023 2
2024 3
2025 7
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study.
Sucuoğlu İşleyen Z, Seçmeler Ş, Sakin A, Cihan Ş, Beşiroğlu M, Kahraman S, Karakurt Eryılmaz M, Zeynelgil E, Çalışkan Yıldırım E, Kut E, Şengül N, Paksoy Türköz F, Alan Ö, Özkul Ö, Işık S, Yılmaz F, Gülmez A, Türker S, Karakaya G, Günaldı M, Özer L, Aksoy A, Karataş F, Sakalar T, Demirtaş Esmer D, Teker F, Demir N, Dülgar Ö, Turhal S, Türk HM, Ertürk K, Çelik E, Atcı MM. Sucuoğlu İşleyen Z, et al. Among authors: caliskan yildirim e. BMC Cancer. 2026 Feb 14. doi: 10.1186/s12885-026-15725-9. Online ahead of print. BMC Cancer. 2026. PMID: 41691201 Free article.
Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study.
Akbas S, Alan O, Yildiz O, Karakurt M, Yildirim EC, Colak R, Yilmaz M, Celebi A, Er O, Celayir OM, Akdag MO, Sacli O, Ozcelik M, Sahin E, Ozdemir M, Dogu GG, Demir A, Gunaltili M, Elcicek OF, Sakalar T, Karabuga B, Yildiz F, Cavdar E, Ozkan O, Ozturk AE, Akagunduz B, Kuvvet BB, Selcukbiricik F. Akbas S, et al. Among authors: yildirim ec. J Neurooncol. 2026 Jan 5;176(2):152. doi: 10.1007/s11060-025-05415-0. J Neurooncol. 2026. PMID: 41492105 No abstract available.
Prognostic importance of CD47 expression on survival of colorectal cancer.
Aktepe OH, Kurtulan O, Dama PE, Yildirim EC, Terzi A, Kalyoncu SA, Atag E, Yavuzsen T, Uner M, Karaoglu A, Yalcin S. Aktepe OH, et al. Among authors: yildirim ec. BMC Gastroenterol. 2025 Oct 24;25(1):757. doi: 10.1186/s12876-025-04371-3. BMC Gastroenterol. 2025. PMID: 41136887 Free PMC article.
17 results